Open App
you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Oct 04, 16:01
4412.00 -8.15 (-0.18%)
Volume
No Data Available
10,787
  • Prev. Close

    4420.15

  • Open Price

    4440.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 04, 15:59
4413.95 -5.70 (-0.13%)
Volume
AVERAGE VOLUME
5-Day
668,093
10-Day
553,241
30-Day
386,619
308,654
  • Prev. Close

    4419.65

  • Open Price

    4446.00

  • Bid Price (Qty.)

    4413.95 (63)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2021 2020 2019 2018 2017
Nine Months Results of Dr Reddys Laboratories (in Rs. Cr.) Dec '21 Dec '20 Dec '19 Dec '18 Dec '17  
Net Sales/Income from operations 10,736.50 9,998.40 8,972.70 7,858.30 6,826.00  
Other Operating Income -- -- 26.00 122.00 41.00  
Total Income From Operations 10,736.50 9,998.40 8,998.70 7,980.30 6,867.00  
EXPENDITURE  
Consumption of Raw Materials 2,051.70 2,450.00 1,902.20 1,579.90 1,437.00  
Purchase of Traded Goods 2,033.50 925.70 891.10 632.10 457.00  
Increase/Decrease in Stocks -333.90 -416.40 -167.10 -40.30 -12.70  
Power & Fuel -- -- -- -- --  
Employees Cost 1,825.70 1,724.50 1,513.60 1,441.90 1,379.70  
Depreciation 609.10 624.30 596.90 576.40 584.10  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- 800.70  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 3,235.30 2,780.70 2,510.10 2,503.60 1,801.80  
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,315.10 1,909.60 1,751.90 1,286.70 419.40  
Other Income 367.30 719.50 615.80 165.70 130.90  
P/L Before Int., Excpt. Items & Tax 1,682.40 2,629.10 2,367.70 1,452.40 550.30  
Interest 25.30 29.80 36.00 48.10 48.70  
P/L Before Exceptional Items & Tax 1,657.10 2,599.30 2,331.70 1,404.30 501.60  
Exceptional Items -- -- -- -- --  
P/L Before Tax 1,657.10 2,599.30 2,331.70 1,404.30 501.60  
Tax 453.60 724.40 -103.20 329.80 111.30  
P/L After Tax from Ordinary Activities 1,203.50 1,874.90 2,434.90 1,074.50 390.30  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 1,203.50 1,874.90 2,434.90 1,074.50 390.30  
Equity Share Capital 83.20 83.10 83.10 83.00 82.90  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 72.56 113.05 146.89 64.75 23.54  
Diluted EPS 72.38 112.73 146.62 64.67 23.49  
EPS After Extra Ordinary  
Basic EPS. 72.56 113.05 146.89 64.75 23.54  
Diluted EPS. 72.38 112.73 146.62 64.67 23.49  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs